In this article, Sue Frankland looks at the global problem of wastage of medications, including causes such as overprescribing and non-adherence. She also presents information from her master’s dissertation on how people understand, and respond to, medication expiration dates
GSK seeks clearance to acquire Pfizer’s consumer healthcare
GSK seeks clearance to acquire Pfizer’s consumer healthcare
The Commerce Commission has received a clearance application from GlaxoSmithKline plc seeking clearance to acquire the consumer healthcare business of Pfizer Inc.
GSK is a global pharmaceuticals company active in the research, development, manufacturing and supply of prescription pharmaceuticals, human vaccines, and consumer healthcare pharmaceuticals that are available without a prescription.
Pfizer is also a global pharmaceuticals company involved in the research, development, manufacturing and supply of medicines. Pfizer’s consumer healthcare business develops, manufactures and supplies non-prescription medicines in the areas of pain management, gastrointestinal health, respiratory, dietary supplements and personal care products.
In New Zealand, both parties supply non-prescription cold and flu treatments and medicines for systemic pain relief.
A public version of the clearance application is available on the Commission’s case register.